Christopher M. Sheth

1.2k citations
11 papers · 806 · 1 hit paper · h-index 9

Impact in

  • Hematology top 5%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
  • Genetics top 10%

Papers in

    • Myeloproliferative Neoplasms: Diagnosis and Treatment 3
    • Acute Myeloid Leukemia Research 4
    • Chronic Myeloid Leukemia Treatments 2

Christopher M. Sheth

11 papers receiving 796 citations

Christopher M. Sheth's Hit Papers

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia 2018 · 255 citations
2550+2+5Years since publication50100150200250

Peers

Christopher M. Sheth
Comparison fields: 5 of 79
  • Hematology 239
  • Genetics 87
  • Biomaterials 114
  • Immunology 141
  • Oncology 174
Replace Annick Tibi with:
Annick Tibi France
S. Danhauser-Riedl Germany
Bobe Petrushev Romania
Alessandro Gulino Italy
Joyce Chan United States
Rob Pieters Netherlands
Maria Braoudaki Greece
Christopher M. Sheth relative to Annick Tibi France Annick Tibi's profile →
Citations per field
00.5×3.2×
Annick Tibi · 1×
Citations per year

Countries citing papers authored by Christopher M. Sheth

Since Specialization
Citations

This map shows the geographic impact of Christopher M. Sheth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Sheth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Sheth more than expected).

Fields of papers citing papers by Christopher M. Sheth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Sheth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Sheth. The network helps show where Christopher M. Sheth may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher M. Sheth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher M. Sheth Line = papers co-authored together Christopher M. Sheth links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Hit paper breakdown →
2018255
2 2019105
3 201996
4 201995
5 201587
6 201966
7 201058
8 200719
9 201710
10 20108
11 20117

About Christopher M. Sheth

Christopher M. Sheth is a scholar working on Genetics, Hematology, Molecular Biology, Pathology and Forensic Medicine and Oncology, having authored 11 papers that have together received 806 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Immunotoxicology and immune responses (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Phosphodiesterase function and regulation (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Nitric Oxide and Endothelin Effects (1 paper) and Chromium effects and bioremediation (1 paper). The work is most often cited by research in Hematology (239 citations), Genetics (87 citations), Biomaterials (114 citations), Immunology (141 citations) and Oncology (174 citations). Christopher M. Sheth has collaborated with scholars based in United States. Frequent co-authors include Richard Pazdur, Donna Przepiorka, Kirsten B. Goldberg, Ann T. Farrell, Yuan Li Shen, Gideon M. Blumenthal, Albert Deisseroth, Xin Gao, Kimber L. White and Kelly J. Norsworthy. Their work appears in journals such as Clinical Cancer Research, Breast Cancer Research and Treatment, The Oncologist, Toxicological Sciences and Journal of Immunotoxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact